111 related articles for article (PubMed ID: 22269478)
1. Analysis of RCAS1 immunoreactivity within hydatidiform mole cells and decidual cells according to the applied therapeutic strategy: surgery or surgery followed by chemotherapy.
Wicherek L; Basta P; Wertel I; Kojs Z; Malkowski B; Grabiec M; Pietrus M; Krystyna G
Gynecol Obstet Invest; 2012; 73(2):106-12. PubMed ID: 22269478
[TBL] [Abstract][Full Text] [Related]
2. The immunohistochemical analysis of RCAS1, HLA-G, and B7H4-positive macrophages in partial and complete hydatidiform mole in both applied therapeutic surgery and surgery followed by chemotherapy.
Basta P; Galazka K; Mach P; Jozwicki W; Walentowicz M; Wicherek L
Am J Reprod Immunol; 2011 Feb; 65(2):164-72. PubMed ID: 20645939
[TBL] [Abstract][Full Text] [Related]
3. Decidual immune cell infiltrate in hydatidiform mole.
Hussein MR; Abd-Elwahed AR; Abodeif ES; Abdulwahed SR
Cancer Invest; 2009 Jan; 27(1):60-6. PubMed ID: 19160109
[TBL] [Abstract][Full Text] [Related]
4. Decidual infiltration of FoxP3⁺ regulatory T cells, CD3⁺ T cells, CD56⁺ decidual natural killer cells and Ki-67 trophoblast cells in hydatidiform mole compared to normal and ectopic pregnancies.
Sundara YT; Jordanova ES; Hernowo BS; Gandamihardja S; Fleuren GJ
Mol Med Rep; 2012 Jan; 5(1):275-81. PubMed ID: 22002546
[TBL] [Abstract][Full Text] [Related]
5. RCAS1 decidual immunoreactivity during stillbirth: immune cell presence and activity.
Galazka K; Wicherek L; Sikora J; Czekierdowski A; Banas T; Bednarek W; Obrzut B; Blecharz P; Reron A; Kalinka J
Am J Reprod Immunol; 2008 Dec; 60(6):513-22. PubMed ID: 19032612
[TBL] [Abstract][Full Text] [Related]
6. No evidence for apoptosis of decidual leucocytes in normal and molar pregnancy: implications for immune privilege.
Pongcharoen S; Bulmer JN; Searle RF
Clin Exp Immunol; 2004 Nov; 138(2):330-6. PubMed ID: 15498045
[TBL] [Abstract][Full Text] [Related]
7. RCAS1 decidual immunoreactivity and RCAS1 serum level during cesarean section with respect to the progression of labor.
Wicherek L; Basta P; Galazka K; Mak P; Dancewicz L; Kalinka J
Am J Reprod Immunol; 2008 Feb; 59(2):152-8. PubMed ID: 18076636
[TBL] [Abstract][Full Text] [Related]
8. RCAS1 decidual immunoreactivity in severe pre-eclampsia: immune cell presence and activity.
Wicherek L; Basta P; Sikora J; Galazka K; Rytlewski K; Grabiec M; Lazar A; Kalinka J
Am J Reprod Immunol; 2007 Oct; 58(4):358-66. PubMed ID: 17845206
[TBL] [Abstract][Full Text] [Related]
9. Expression of Fas/Fas ligand by decidual leukocytes in hydatidiform mole.
Wongweragiat S; Searle RF; Bulmer JN
Biol Reprod; 2001 Mar; 64(3):784-9. PubMed ID: 11207192
[TBL] [Abstract][Full Text] [Related]
10. Comparison of immunosuppressive properties of hydatidiform mole decidua and trophoblast extracts.
Bennett WA; Brackin MN; Long CA; Cowan BD
Am J Reprod Immunol; 1996 Aug; 36(2):86-9. PubMed ID: 8862251
[TBL] [Abstract][Full Text] [Related]
11. RCAS1 decidual immunoreactivity during cesarean section in scar deciduosis: immune cell presence and activity.
Skret-Magierlo J; Wicherek L; Basta P; Galazka K; Sikora J; Wilk M; Fudali L; Skret A
Gynecol Obstet Invest; 2008; 65(3):187-94. PubMed ID: 18032910
[TBL] [Abstract][Full Text] [Related]
12. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
13. Decidual T lymphocyte activation in hydatidiform mole.
Wongweragiat S; Searle RF; Bulmer JN
J Clin Pathol; 1999 Dec; 52(12):888-94. PubMed ID: 10711251
[TBL] [Abstract][Full Text] [Related]
14. RCAS1 decidual immunoreactivity during placental abruption: immune cell presence and activity.
Wicherek L; Galazka K; Lazar A
Am J Reprod Immunol; 2007 Jul; 58(1):46-55. PubMed ID: 17565547
[TBL] [Abstract][Full Text] [Related]
15. Measurement of CA-125 in trophoblastic disease.
Kohorn EI
Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
[TBL] [Abstract][Full Text] [Related]
16. Guidelines following hydatidiform mole: a reappraisal.
Kerkmeijer L; Wielsma S; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):112-8. PubMed ID: 16638032
[TBL] [Abstract][Full Text] [Related]
17. Analysis of metallothionein, RCAS1 immunoreactivity regarding immune cell concentration in the endometrium and tubal mucosa in ectopic pregnancy during the course of tubal rupture.
Wicherek L; Galazka K; Lazar A
Gynecol Obstet Invest; 2008; 65(1):52-61. PubMed ID: 17717421
[TBL] [Abstract][Full Text] [Related]
18. The immunohistochemical analysis of antigens such as RCAS1 and B7H4 in the cervical cancer nest and within the fibroblasts and macrophages infiltrating the cancer microenvironment.
Galazka K; Opławski M; Windorbska W; Skret-Magierlo J; Koper K; Basta P; Mach P; Dutch-Wicherek M; Mazur A; Wicherek L
Am J Reprod Immunol; 2012 Jul; 68(1):85-93. PubMed ID: 22530960
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic chemotherapy of complete molar pregnancy.
Goldstein DP; Berkowitz RS
Semin Oncol; 1995 Apr; 22(2):157-60. PubMed ID: 7740316
[No Abstract] [Full Text] [Related]
20. Repetitive complete and partial hydatidiform mole.
Rice LW; Lage JM; Berkowitz RS; Goldstein DP; Bernstein MR
Obstet Gynecol; 1989 Aug; 74(2):217-9. PubMed ID: 2748058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
